Stay updated with breaking news from Revised Forecast. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immatics (IMTX) expanded its collaboration with Bristol Myers Squibb (BMY) to develop multiple allogeneic off-the-shelf TCR-T and/or CAR-T programs.Under the agreement, Immatics...
DGAP-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Foreca...
DGAP-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS) 03-Feb-2022
DGAP-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS) 03-Feb-2022 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation ...
Takeda Pharmaceutical Company Limited / Key word(s): ForecastTakeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)03-Feb-2022 / 07:00 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP...